Back to User profile » Prof. Dr. Jalid Sehouli
Papers published by Prof. Dr. Jalid Sehouli:
Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer
Mao X, Dong B, Gao M, Ruan G, Huang M, Braicu EI, Sehouli J, Sun P
OncoTargets and Therapy 2019, 12:6757-6767
Published Date: 20 August 2019
Key regulator of cellular metabolism, estrogen-related receptor α, a new therapeutic target in endocrine-related gynecological tumor
Liu G, Sun P, Dong B, Sehouli J
Cancer Management and Research 2018, 10:6887-6895
Published Date: 12 December 2018
Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA
Sun PM, Mao XD, Gao M, Huang MM, Chen LL, Ruan GY, Huang WY, Braicu EI, Sehouli J
Cancer Management and Research 2018, 10:2521-2535
Published Date: 10 August 2018
The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis
Ruan GY, Ye LX, Liu GF, An J, Sehouli J, Sun PM
OncoTargets and Therapy 2018, 11:521-528
Published Date: 23 January 2018
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
Braicu EI, Luketina H, Richter R, Cacsire Castillo-Tong D, Lambrechts S, Mahner S, Concin N, Mentze M, Zeillinger R, Vergote I, Sehouli J
OncoTargets and Therapy 2014, 7:1563-1569
Published Date: 11 September 2014